Eshyasi Pharma Limited, a active public limited company, was established on 04 February 2008 in Baroda, Gujarat, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232GJ2008PLC052796. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
Formerly known as Tonira Chemical Company Limited. It upholds a compliant status. Employing 2 professional, Its leadership includes Shachi Monik Shah (Director), Nisha Mahesh Shah (Director), Monik Mahesh Shah (Whole-Time Director). Past directors included Sasidharan Narayanan Nair, Ramniwas Parbhatilal Jangir, Shachi Monik Shah. It holds ₹1.57 M open charges and ₹1.95 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-7 # 31,32,33 Krishna Industrial Estate, Opposite Bidc, Gorwa,, Baroda, Gujarat, 390016.
U24232GJ2008PLC052796
052796
04 February 2008
₹5.00 M
₹5.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Eshyasi Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shachi Monik Shah | Director | 04 Aug 2010 | Current |
| Nisha Mahesh Shah | Director | 04 Aug 2010 | Current |
| Monik Mahesh Shah | Whole-Time Director | 03 Oct 2008 | Current |
| Mahesh Natvarlal Shah | Whole-Time Director | 04 Feb 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 04 Aug 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Apr 2009 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Additional Director | 01 Apr 2009 | Past |
| Pramod Abcsdd | Whole-Time Director | 05 Aug 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eshyasi Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 92.79% increase. The company also saw a substantial improvement in profitability, with a 25.15% increase in profit. The company's net worth observed a substantial decline by a decrease of 45.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Eshyasi Pharma had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,569,000.00
₹19,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Nov 2023 | Hdfc Bank Limited | ₹0.75 M | Open |
| 22 Nov 2023 | Hdfc Bank Limited | ₹0.82 M | Open |
| 03 Jun 2016 | Hdfc Bank Limited | ₹1.95 Cr | Satisfied |
Explore comprehensive loan charge details -
Eshyasi Pharma has a workforce of 2 employees as of Sep 17, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Eshyasi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eshyasi Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Eshyasi Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Eshyasi Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 0.75 M with Charge ID 100849272 was registered on 28 Nov 2023. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 0.82 M with Charge ID 100849267 was registered on 22 Nov 2023. was recorded as a recent event.
The activity A charge registered on 03 Jun 2016 via Charge ID 100029899 with Hdfc Bank Limited was fully satisfied on 11 Oct 2021. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 19.50 M with Charge ID 100029899 was registered on 03 Jun 2016. was completed.
The CIN of Eshyasi Pharma Limited is U24232GJ2008PLC052796.
Eshyasi Pharma Limited is headquartered at B-7 # 31,32,33 Krishna Industrial Estate, Opposite Bidc, Gorwa,, Baroda, Gujarat, 390016.
Eshyasi Pharma Limited was incorporated on 04 February 2008.
The current directors of Eshyasi Pharma Limited are
The primary industry of Eshyasi Pharma Limited is Manufacturing.
Eshyasi Pharma Limited is unlisted.
The authorized capital of Eshyasi Pharma Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Eshyasi Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX